medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2022, Number 4

<< Back Next >>

Rev Nefrol Dial Traspl 2022; 42 (4)

Comparison of Lower and Upper Limb Remote Ischemic Preconditioning to Prevent Contrast-Induced Nephropathy: A Randomized Pilot Study with a Control Group

Uzun S, Cebeci E, Dogan O, Senel OTE, Can O, Durmus G, Yigit N, Can MM, Ozturk S

Language: English
References: 26
Page: 296-306
PDF size: 277.57 Kb.


ABSTRACT

Background: The role of remote ischemic preconditioning (RIPC) in preventing the development of contrast-induced nephropathy (CIN) and whether there is a difference between the results of applications of RIPC to the upper or lower extremities has not been adequately demonstrated. Methods: We included the patients who underwent coronary angiography due to stable angina pectoris in this single center, randomized, pilot study. We randomly enrolled a total of 168 patients in one of three groups (60 patients in the upper limb RIPC group, 58 patients in the lower limb RIPC group, and 50 patients in the control group). Results: According to the Acute Kidney Injury Network (AKIN), CIN did not develop in any RIPC patients and developed in 6% of controls (OR: 3.511, 95% CI: 2.757-4.471, p=0.025). According to the European Society of Urogenital Radiology (ESUR) guidelines, CIN developed in 1.7% of RIPC patients and 8% of controls (p=0.065). It was found that creatinine levels increased in the control group and decreased in the RIPC groups (baseline: 0.81±0.19mg/dL and 0.86±0.25mg/dL and control: 0.76±0.17mg/dL and 0.91±0.36mg/ dL, p ‹0.001). When the upper and lower limb RIPC results were compared, there was no statistically significant difference in the incidence of CIN. In multivariate analyses we found out that baseline eGFR, baseline mean blood pressure, contrast agent volume, and RIPC were independently associated with the development of CIN. Conclusions: RIPC is a practically useful method in preventing CIN in patients undergoing coronary angiography. Upper or lower-limb RIPC applications seem to have a similar effect.


REFERENCES

  1. Writing Group Members, Mozaffarian D, BenjaminEJ, Go AS, Arnett DK, Blaha MJ, Cushman M, etal. American Heart Association Statistics Committee;Stroke Statistics Subcommittee: ExecutiveSummary: Heart Disease and Stroke Statistics-2016Update: A Report from the American HeartAssociation. Circulation 133: 447-454. DOI:10.1161/CIR.0000000000000366.

  2. Yücel Balbay, Selim Bener, Taner Kaygusuz, SerkanÇay, Erdoğan İlkay. Koroner revaskülarizasyon(Dünya ve Türkiye örnekleri). Arch Turk Soc Cardiol2014; 42: 245-252. DOI: 10.5543/tkda.2014.49765.

  3. Jurado-Román A, Hernández-Hernández F, García-Tejada J, Granda-Nistal C, Molina J, Velázquez M, etal. Role of hydration in contrast-induced nephropathyin patients who underwent primary percutaneouscoronary intervention. Am J Cardiol.2015; 115: 1174-1178. DOI: 10.1016/j.amjcard.2015.02.004.

  4. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD,Genge M, Withers J, et al. Contrast material-inducedrenal failure in patients with diabetes mellitus, renalinsufficiency, or both. A prospective controlled study.N Engl J Med.1989; 320:143-149. DOI: 10.1056/NEJM198901193200303.

  5. Nash K, Hafeez A, Hou S. Hospital-acquired renalinsufficiency. Am J Kidney Dis. 2002; 39: 930-936.DOI: 10.1053/ajkd.2002.32766.

  6. Gonzales DA, Norsworthy KJ, Kern SJ, BanksS, Sieving PC, Star RA, et al. A meta-analysis ofN-acetylcysteine in contrast-induced nephrotoxicity:unsupervised clustering to resolve heterogeneity. BMCMed. 2007; 5: 32. DOI: 10.1186/1741-7015-5-32.

  7. Leoncini M, Toso A, Maioli M, Tropeano F, Villani S,Bellandi F. Early high-dose rosuvastatin for contrastinducednephropathy prevention in acute coronarysyndrome: Results from the PRATO-ACS Study(Protective Effect of Rosuvastatin and AntiplateletTherapy On contrast-induced acute kidney injury andmyocardial damage in patients with Acute CoronarySyndrome). J Am Coll Cardiol. 2014; 63: 71-79. DOI:10.1016/j.jacc.2013.04.105.

  8. Spargias K, Alexopoulos E, Kyrzopoulos S, IokovisP, Greenwood DC, Manginas A, et al. Ascorbic acidprevents contrast-mediated nephropathy in patients withrenal dysfunction undergoing coronary angiography orintervention. Circulation 2004; 110: 2837-2842. DOI:10.1161/01.CIR.0000146396.19081.73.

  9. Murry CE, Jennings RB, Reimer KA. (1986)Preconditioning with ischemia: a delay of lethal cellinjury in ischemic myocardium. Circulation 1986; 74:1124-1136. DOI: 10.1161/01.cir.74.5.1124.

  10. Er F, Nia AM, Dopp H, Hellmich M, DahlemKM, Caglayan E, et al. Ischemic preconditioning forprevention of contrast medium-induced nephropathy:randomized pilot RenPro Trial (Renal ProtectionTrial). Circulation 2012; 126: 296-303. DOI: 10.1161/CIRCULATIONAHA.112.096370.

  11. Deftereos S, Giannopoulos G, Tzalamouras V, RaisakisK, Kossyvakis C, Kaoukis A, et al. Renoprotective effectof remote ischemic post-conditioning by intermittentballoon inflations in patients undergoing percutaneouscoronary intervention. J Am Coll Cardiol. 2013; 61:1949-1955. DOI: 10.1016/j.jacc.2013.02.023.

  12. Yamanaka T, Kawai Y, Miyoshi T, Mima T, TakagakiK, Tsukuda S, et al. Remote ischemic preconditioningreduces contrast-induced acute kidney injury inpatients with ST-elevation myocardial infarction: arandomized controlled trial. Int J Cardiol. 2015; 178:

  13. 136-141. DOI: 10.1016/j.ijcard.2014.10.135.13. Zhou F, Song W, Wang Z, Yin L, Yang S, Yang F,et al. Effects of remote ischemic preconditioning oncontrast-induced nephropathy after percutaneouscoronary intervention in patients with the acutecoronary syndrome. Medicine (Baltimore) 2018; 97:9579. DOI: 10.1097/MD.0000000000009579.

  14. Moretti C, Cerrato E, Cavallero E, Lin S, Rossi ML,Picchi A, et al. The EUROpean and Chinese cardiacand renal Remote Ischemic Preconditioning Study(EURO-CRIPS CardioGroup I): A randomizedcontrolled trial. Int J Cardiol. 2018; 257: 1-6. DOI:10.1016/j.ijcard.2017.12.033.

  15. Zarbock A, Kellum JA. Remote IschemicPreconditioning and Protection of the Kidney--ANovel Therapeutic Option. Crit Care Med. 2016; 44:607-616. DOI: 10.1097/CCM.0000000000001381.

  16. Wever KE, Warlé MC, Wagener FA, van der HoornJW, Masereeuw R, van der Vliet JA, et al. Remoteischaemic preconditioning by brief hind limbischaemia protects against renal ischaemia-reperfusioninjury: the role of adenosine. Nephrol Dial Transplant.2011; 26: 3108-3117. DOI: 10.1093/ndt/gfr103.

  17. Mehran R, Aymong ED, Nikolsky E, Lasic Z, IakovouI, Fahy M, et al. A simple risk score for prediction ofcontrast-induced nephropathy after percutaneouscoronary intervention: development and initialvalidation. J Am Coll Cardiol. 2004; 44: 1393-1399.DOI: 10.1016/j.jacc.2004.06.068.

  18. Zarbock A, Schmidt C, Van Aken H, Wempe C,Martens S, Zahn PK, et al. RenalRIPC Investigators.Effect of remote ischemic preconditioning on kidneyinjury among high-risk patients undergoing cardiacsurgery: a randomized clinical trial. JAMA 2015; 313:2133-2141. DOI: 10.1001/jama.2015.4189.

  19. Thomsen HS, Morcos SK. Contrast media and thekidney: European Society of Urogenital Radiology(ESUR) guidelines. Br J Radiol. 2003; 76: 513-518.DOI: 10.1259/bjr/26964464.

  20. Mehta RL, Kellum JA, Shah SV, Molitoris BA, RoncoC, Warnock DG, et al. Acute Kidney Injury Network.Acute Kidney Injury Network: report of an initiativeto improve outcomes in acute kidney injury. Crit Care2007;11: R31, DOI: 10.1186/cc5713.

  21. Levey AS, Coresh J, Greene T, Stevens LA, ZhangYL, Hendriksen S, et al. Chronic Kidney DiseaseEpidemiology Collaboration: Using standardizedserum creatinine values in the modification of diet inrenal disease study equation for estimating glomerularfiltration rate. Ann Intern Med.2006; 145: 247-254.DOI: 10.7326/0003-4819-145-4-200608150-00004.

  22. Deng J, Lu Y, Ou J, Shao X, Wang X, Xie H. RemoteIschemic Preconditioning Reduces the Risk of Contrast-Induced Nephropathy in Patients with Moderate RenalImpairment Undergoing Percutaneous CoronaryAngiography: A Meta-Analysis. Kidney Blood Press Res.2020; 45: 549-564. DOI: 10.1159/000507330.

  23. Gholoobi A, Sajjadi SM, Shabestari MM, EshraghiA, Shamloo AS. The Impact of Remote IschemicPre-Conditioning on Contrast-Induced Nephropathyin Patients Undergoing Coronary Angiography andAngioplasty: A Double-Blind Randomized ClinicalTrial. Electron Physician 2015; 7: 1557-1565. DOI:10.19082/1557.

  24. Stokfisz K, Ledakowicz-Polak A, Kidawa M,Zielinska M. Remote Ischemic Preconditioningand Contrast-Induced Acute Kidney Injury inPatients Undergoing Elective Percutaneous CoronaryIntervention: A Randomized Clinical Trial. CurrTher Res Clin Exp. 2020; 93: 100599. DOI: 10.1016/j.curtheres.2020.100599.

  25. Menting TP, Sterenborg TB, de Waal Y, DondersR, Wever KE, Lemson MS, Et al. Remote IschemicPreconditioning to Reduce Contrast-InducedNephropathy: A Randomized Controlled Trial. Eur JVasc Endovasc Surg. 2015; 50: 527-532. DOI: 10.1016/j.ejvs.2015.04.002.

  26. Hu J, Liu S, Jia P, Xu X, Song N, Zhang T, et al.Protection of remote ischemic preconditioningagainst acute kidney injury: a systematic review andmeta-analysis. Crit Care. 2016 Apr 20;20(1):111HuJ, Liu S, Jia P et al. Protection of remote ischemicpreconditioning against acute kidney injury: asystematic review and meta-analysis. Crit Care 2016;20: 111. DOI: 10.1186/s13054-016-1272-y.




2020     |     www.medigraphic.com